JAMES HUANG
Executive Chairman
Mr. Huang has over 27 years of executive leadership and investment experience in the Biotech Industry, with a MBA from Stanford University. Since the founding of the Company, Mr. Huang was appointed to be the Executive Chairman, to further grow the Company both as the largest investor’s representative (Kleiner Perkins) and also as a seasoned biotech executive. He is currently Managing Partner at Kleiner Perkins Greater China and Founding Partner at Panacea Venture, as well as Director for the board of multiple biotech companies, both privately and publically listed in the US, China, and Hong Kong.
BRYANT FONG
Director of the Board
Mr. Fong has more than 23 years of experience in biotechnology and investment management. He is currently a founding General and Managing Partner of Biomark Capital, a $200+ million life science fund, established in 2013. Prior to forming Biomark Capital, he was with Burrill Capital Management managing life science funds with committed capital over $1 billion. Mr. Fong has played a lead role in over 25 private and public life science financings and currently serves on the boards of directors of a number of private life science companies. Mr. Fong earned his B.A. with honors in Molecular and Cell Biology-Biochemistry from the University of California, Berkeley.
SCOTT LIU, PH.D.
Director of the Board
Dr. Liu has more than 25 years of experience in biopharmaceutical R&D, manufacturing and quality management. Dr. Liu previously retired from Shanghai Henlius Biotech, Inc. (2696.HK) which he Co-Founded in 2010, held positions as President & CEO, and was integral in building the company to have a valuation of over 20 Billion HKD. Prior to Co-Founding Henlius, he held several executive positions, including Vice President at United Biomedical as well as holding executive positions in quality at Bristol-Myers Squibb and Amgen. Dr. Liu received his Ph.D. degree in Biology from Purdue University with postdoctoral training in Biology at Stanford University.
Eden Biologics’ leadership team is dedicated to fostering a dynamic change-driven culture
committed to meetin the needs or our customers